20th Jan 2016 08:43
LONDON (Alliance News) - Regenerative medical devices maker Tissue Regenix Group PLC on Wednesday said its DermaPure wound care products has surpassed the USD1.0 million sales mark.
The boost came after the product was awarded the Medicare 'Q' code for reimbursement in the US, which became effective on January 1 and meant the product was made available to 65% of Medicare beneficiaries in the US across 31 states.
DermaPure is used for a number of treatments, including for pressure ulcers and frostbite, Tissue Regenix said.
Shares in the company were up 9.1% to 15.00 pence early Wednesday.
By Sam Unsted; [email protected]; @SamUAtAlliance
Copyright 2016 Alliance News Limited. All Rights Reserved.
Related Shares:
Tissue Regenix Group